Abstract

Much of the recent advances in gastroenterology has focused on the small bowel. Reimbursement is generally poor considering the time, expertise, and equipment required. Our current billing system lags behind technology and as a result, many of these newer procedures operate at a net loss in income. Previous studies have shown that downstream revenue generation from other resource intensive procedures such as ERCP, EUS, and EMR attenuates the loss of income from the procedure itself. No studies to date have specifically analyzed small bowel-directed endoscopies and their revenue generating profile.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call